Oral Session 2-11C Novel therapies for ALL

[OS2-11C-4] Hyper-CMAD with liposomal vincristine in patients with newly diagnosed acute lymphoblastic leukemia

Koji Sasaki¹, Elias Jabbour¹, Maria Khouri¹, Deborah Thomas¹, Guillermo Garcia-Manero¹, Farhad Ravandi¹, Gautam Borthakur¹, Nicholas Short¹, Ghayas Issa¹, Tapan Kadia¹, Emily Jones¹, Rebecca Garris¹, Jorge Cortes¹, Susan Obrien², Hagop Kantarjian¹ (1.MD Anderson Cancer Center, Houston, TX, U.S.A., 2.The University of California, Irvine, U.S.A.)